Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2825 of 3284 entries
View as:

Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTION

Phase: N/A Priority: Normal
NCT ID: NCT00526721 Org: User:
Start: 05/31/07 End: 04/30/08 Due: 04/30/09

To Assess the Safety, Tolerability and Pharmacokinetics of AZD5634 Following Inhaled and Intravenous (IV)Dose Administration

Phase: N/A Priority: Normal
NCT ID: NCT02679729 Org: User:
Start: 02/11/16 End: 10/24/16 Due: 10/24/17

A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued

Phase: N/A Priority: Normal
NCT ID: NCT00633672 Org: User:
Start: 02/28/01 End: 10/31/03 Due: 10/31/04

Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01159145 Org: User:
Start: 07/31/10 End: 09/30/10 Due: 09/30/11

PICAROS - Acalabrutinib RWE on 1L CLL in Spain

Phase: N/A Priority: Normal
NCT ID: NCT05999877 Org: User:
Start: 07/11/23 End: 12/31/26 Due: 12/31/27

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

Phase: N/A Priority: Normal
NCT ID: NCT00083954 Org: User:
Start: 06/30/04 End: 08/31/05 Due: 08/31/06

Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT01208961 Org: User:
Start: 09/30/10 End: 11/30/10 Due: 11/30/11

Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04416633 Org: User:
Start: 11/30/21 End: 10/27/23 Due: 10/27/24

A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.

Phase: N/A Priority: Normal
NCT ID: NCT04612790 Org: User:
Start: 03/31/21 End: 10/26/23 Due: 10/26/24

A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Phase: N/A Priority: Normal
NCT ID: NCT00327015 Org: User:
Start: 05/31/06 End: 12/31/08 Due: 12/31/09

D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT01851265 Org: User:
Start: 07/04/13 End: 06/06/17 Due: 06/06/18

Crestor Versus Placebo in Subjects With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00206310 Org: User:
Start: 09/30/03 End: 07/31/07 Due: 07/31/08

A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT04072562 Org: User:
Start: 09/19/19 End: 11/28/19 Due: 11/28/20

Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD

Phase: N/A Priority: Normal
NCT ID: NCT00524355 Org: User:
Start: 03/31/07 End: 11/30/07 Due: 11/30/08

Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03645421 Org: User:
Start: 08/10/18 End: 01/17/19 Due: 01/17/20

A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients With a History of Myocardial Infarction and Additional Risk Factors for Atherothrombosis

Phase: N/A Priority: Normal
NCT ID: NCT01984307 Org: User:
Start: 08/31/13 End: 11/30/13 Due: 11/30/14

A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas

Phase: N/A Priority: Normal
NCT ID: NCT00313313 Org: User:
Start: 04/30/06 End: 09/30/08 Due: 09/30/09

Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00562250 Org: User:
Start: 05/31/08 End: 08/31/08 Due: 08/31/09

forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)

Phase: N/A Priority: Normal
NCT ID: NCT01944618 Org: User:
Start: 10/31/13 End: 10/31/15 Due: 10/31/16

Pharmacokinetics in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01196689 Org: User:
Start: 10/31/10 End: 02/28/11 Due: 02/28/12

A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT00505388 Org: User:
Start: 07/31/07 End: 04/30/10 Due: 04/30/11

Better Diabetes Control, Quality - Educate to Achieve Compliance.

Phase: N/A Priority: Normal
NCT ID: NCT01728714 Org: User:
Start: 05/19/14 End: 12/05/18 Due: 12/05/19

Long-term Observational Study of the Safety of Roflumilast

Phase: N/A Priority: Normal
NCT ID: NCT03381573 Org: User:
Start: 12/15/13 End: 09/16/22 Due: 09/16/23

Prevalence of the Eosinophilic Phenotype Among Severe Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT03931954 Org: User:
Start: 05/15/19 End: 11/26/20 Due: 11/26/21

Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans

Phase: N/A Priority: Normal
NCT ID: NCT00702325 Org: User:
Start: 06/30/08 End: 09/30/09 Due: 09/30/10